Sunday, January 31, 2010

Belgian biopharma co UCB cancels Teva deal

Belgian biopharma co UCB cancels Teva deal


Globes - 55 minutes ago

UCB said that Teva will undertake full commercial responsibility for the marketing of its ProAir asthma inhaler. Belgian biopharmaceutical company UCB SA (Euronext: UCB) plans to accelerate its US ...


http://digg.com/u1LqRw

No comments:

Post a Comment